Form 486BPOS - Post-effective amendment [Rule 485(b)]:
SEC Accession No. 0001341004-18-000252
Filing Date
2018-04-27
Accepted
2018-04-27 16:32:45
Documents
10
Effectiveness Date
2018-04-27

Document Format Files

Seq Description Document Type Size
1 486BPOS bme_486b.htm 486BPOS 2036073
2 EXHIBIT (G)(2) - CLOSED-END FUND MASTER ADVISORY FEE WAIVER AGREEMENT exg2.htm EX-99.2G ADVSR CONTR 139625
3 EXHIBIT (H)(2) - SECOND AMENDED AND RESTATED DISTRIBUTION AGREEMENT exh2.htm EX-99.2H DISTR CONTR 87838
4 EXHIBIT (H)(4) - AMENDMENT TO THE SUB-PLACEMENT AGENT AGREEMENT exh4.htm EX-99.2H DISTR CONTR 83544
5 EXHIBIT (N) - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE R exn.htm EX-99.2N OTH CONSENT 1942
6 EXHIBIT (S)(3) exs3.htm EX-1 5900
7 image00001.jpg GRAPHIC 90718
8 image1.jpg GRAPHIC 130957
9 image2.jpg GRAPHIC 99697
10 image3.jpg GRAPHIC 100507
  Complete submission text file 0001341004-18-000252.txt   2937527
Mailing Address 100 BELLEVUE PARKWAY WILMINGTON DE 19809
Business Address 100 BELLEVUE PARKWAY WILMINGTON DE 19809 (888) 825-2257
BlackRock Health Sciences Trust (Filer) CIK: 0001314966 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: 486BPOS | Act: 33 | File No.: 333-210770 | Film No.: 18784498

Mailing Address 100 BELLEVUE PARKWAY WILMINGTON DE 19809
Business Address 100 BELLEVUE PARKWAY WILMINGTON DE 19809 (888) 825-2257
BlackRock Health Sciences Trust (Filer) CIK: 0001314966 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: 486BPOS | Act: 40 | File No.: 811-21702 | Film No.: 18784499